Clinical trial
An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid…
NCT00264550 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00264550 |
|---|---|
| Title | An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlledTrial of Golimumab, a Fully Human Anti-TNFa MonoclonalAntibody, Administered Subcutaneously, in Subjects With ActiveRheumatoid Arthritis Despite Methotrexate Therapy |
| Acronym | GO-FORWARD |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Golimumab 100 mg, Golimumab 50 mg, Methotrexate, Placebo injection, Placebo capsules |
| Enrollment | 444 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | May 1, 2012 |
| First posted | Dec 13, 2005 |
| Last update posted | Apr 29, 2014 |
| Countries | Argentina, Australia, Canada, Chile, Germany, Hungary, Mexico, New Zealand, Poland, South Korea, Taiwan, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: